Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

2.80
-0.1500-5.08%
Post-market: 2.850.0500+1.79%19:05 EDT
Volume:64.43K
Turnover:180.19K
Market Cap:17.69M
PE:-0.63
High:3.04
Open:3.04
Low:2.71
Close:2.95
52wk High:17.75
52wk Low:1.20
Shares:6.32M
Float Shares:3.55M
Volume Ratio:0.74
T/O Rate:1.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4457
EPS(LYR):-9.8491
ROE:-320.20%
ROA:-46.32%
PB:2.84
PE(LYR):-0.28

Loading ...

Jan 12, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Apr 28, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Aug 24, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 22, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jul 07, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Jun 01, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 31, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 26, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
May 13, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 07, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 06, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 25, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Jan 22, 2021

Correspondence

CORRESP [Cover] - Correspondence